CRP and hepatocellular carcinoma: Immunoinflammatory biomarkers, such as C-reactive protein (CRP), prognostic nutritional index (PNI), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and the systemic immune-inflammation index (SII), have shown promising predictive value for prognosis in hepatocellular carcinoma (HCC) patients [18–20].